V. Brunner

A pharmacogically guided phase I study of carboplatin in combination with methotrexate and vinblastine in advanced urothelial cancer

G. Houin, P. Canal, C. Chevreau, 2009, Cancer Chemotherapy and Pharmacology.

Prediction of carboplatin clearance from standard morphological and biological patient characteristics.

G. Houin, P. Canal, C. Chevreau, 1995, Journal of the National Cancer Institute.

A novel psychoanalytical approach: An electrochemical ligand-binding assay to screen antipsychotics.

Sandro Carrara, Tugba Kilic, Valerie Brunner, 2018, Biosensors & bioelectronics.

Disposition and metabolism of [14C]-levomilnacipran, a serotonin and norepinephrine reuptake inhibitor, in humans, monkeys, and rats

Laishun Chen, P. Hermann, L. Roques, 2015, Drug design, development and therapy.

Randomized, double-blind, placebo-controlled study of F17464, a preferential D3 antagonist, in the treatment of acute exacerbation of schizophrenia

J. Lieberman, I. Bitter, P. Sokoloff, 2019, Neuropsychopharmacology.

Propranolol pharmacokinetics in infants treated for Infantile Hemangiomas requiring systemic therapy: Modeling and dosing regimen recommendations

S. Barbarot, L. Guibaud, A. Delarue, 2018, Pharmacology research & perspectives.

Binding of the D3-preferring antipsychotic candidate F17464 to dopamine D3 and D2 receptors: a PET study in healthy subjects with [11C]-(+)-PHNO

Simon K Joseph, P. Sokoloff, T. Cooper, 2019, Psychopharmacology.